Phosphagenics Signs Agreement with Japanese Pharmaceutical Company –

This agreement is the second arrangement negotiated by Phosphagenics for TPM/diclofenac and follows last year’s licensing agreement with Themis Medicare Limited for the Indian market. In addition, the company is in early discussions with a large company …

Leave a Reply

Your email address will not be published.